Filing Details
ACTUATE THERAPEUTICS, INC. (NASDAQ:ACTU) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedNASDAQ:ACTU
ACTUATE THERAPEUTICS, INC. (ACTU) Reports Material Event to SEC
Filing Details ACTUATE THERAPEUTICS, INC. (NASDAQ:ACTU) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context…
Market Context
ACTUATE THERAPEUTICS, INC.'s stock currently trades at $1.44 with a market capitalization of $86.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for ACTUATE THERAPEUTICS, INC.'s stock.
All SEC filings for ACTUATE THERAPEUTICS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ACTU Stock Page
Frequently Asked Questions
Where can I read ACTU's SEC filings?
Browse all filings on our ACTU SEC filings page.
What types of SEC filings does ACTUATE THERAPEUTICS, INC. file?
Public companies like ACTUATE THERAPEUTICS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.